HeartBeam Current Ratio 2020-2024 | BEAT

HeartBeam current ratio from 2020 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
HeartBeam Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-12-31 $0.00B $0.00B 1.71
2024-09-30 $0.01B $0.00B 3.31
2024-06-30 $0.01B $0.00B 6.83
2024-03-31 $0.01B $0.00B 12.07
2023-12-31 $0.02B $0.00B 14.09
2023-09-30 $0.02B $0.00B 19.12
2023-06-30 $0.02B $0.00B 37.95
2023-03-31 $0.00B $0.00B 0.63
2022-12-31 $0.00B $0.00B 2.43
2022-09-30 $0.01B $0.00B 7.16
2022-06-30 $0.01B $0.00B 12.65
2022-03-31 $0.01B $0.00B 24.79
2021-12-31 $0.01B $0.00B 23.81
2021-09-30 $0.00B $0.01B 0.16
2021-06-30 $0.00B 0.00
2021-03-31 $0.00B 0.00
2020-12-31 $0.00B 0.00
2020-09-30 $0.00B 0.00
2019-12-31 $0.00B $0.00B 0.02
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.055B $0.000B
HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology. HeartBeam Inc. is based in SANTA CLARA, Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $35.134B 48.53
Tempus AI (TEM) United States $6.966B 0.00
Hims & Hers Health (HIMS) United States $6.050B 97.25
Inspire Medical Systems (INSP) United States $4.470B 86.83
IRhythm Technologies (IRTC) United States $3.223B 0.00
Privia Health (PRVA) United States $2.873B 215.27
Schrodinger (SDGR) United States $1.881B 0.00
Clover Health Investments (CLOV) United States $1.839B 0.00
Enovis (ENOV) United States $1.825B 11.29
Omnicell (OMCL) United States $1.418B 30.59
Phreesia (PHR) United States $1.409B 0.00
Azenta (AZTA) United States $1.154B 53.72
10x Genomics (TXG) United States $0.918B 0.00
Butterfly Network (BFLY) United States $0.568B 0.00
Fulgent Genetics (FLGT) United States $0.551B 0.00
Talkspace (TALK) United States $0.450B 267.00
Veradigm (MDRX) United States $0.449B 0.00
Standard BioTools (LAB) United States $0.440B 0.00
TruBridge (TBRG) United States $0.363B 0.00
Claritev (CTEV) United States $0.325B 0.00
Health Catalyst (HCAT) United States $0.270B 0.00
Nyxoah SA (NYXH) Belgium $0.206B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.189B 0.00
Pulmonx (LUNG) United States $0.182B 0.00
American Well (AMWL) United States $0.109B 0.00
EUDA Health Holdings (EUDA) Singapore $0.100B 0.00
Retrieve Medical Holdings (RMHI) United States $0.082B 0.00
MDxHealth SA (MDXH) Belgium $0.076B 0.00
P3 Health Partners (PIII) United States $0.066B 0.00
111 (YI) China $0.064B 0.00
CareCloud (CCLD) United States $0.060B 2.58
Outset Medical (OM) United States $0.040B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Precipio (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Syra Health (SYRA) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00